Search research articles
Contact Us
Filters
Showing results (51-60 of 318) with videos related to
Page
of 32
Sort By:
The Australasian Journal of Dermatology
|
February 14, 2004
Treatment of primary cutaneous follicular centre lymphoma with rituximab: a report of two cases
Glen A Kennedy, Robert Blum, Christopher McCormack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Erdheim-Chester disease harboring the BRAF V600E mutation
Piers Blombery, Stephen Q Wong, Stephen Lade, et al.
Journal of the American Academy of Dermatology
|
November 14, 2006
Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases
Hope V Dinh, Christopher McCormack, Stephen Hall, et al.
European Journal of Haematology
|
July 5, 2007
Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison
H Miles Prince, Michael Adena, Dell Kingsford Smith, et al.
International Journal of Hematology
|
February 11, 2010
Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient
Alastair B Law, Gail Ryan, Stephen Lade, et al.
The Australasian Journal of Dermatology
|
November 21, 2024
Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib
Harmeet K Bhullar, Friyana Bhabha, Chris McCormack, et al.
Expert Review of Anticancer Therapy
|
March 28, 2008
Histone deacetylase inhibitors in lymphoma and solid malignancies
Walid Rasheed, Mark Bishton, Ricky W Johnstone, et al.
Leukemia & Lymphoma
|
February 7, 2009
Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma
Stefan Peinert, Sarah Kamel, John F Seymour, et al.
Ophthalmology
|
May 10, 2014
Adult orbital xanthogranuloma successfully treated with rituximab
Khami Satchi, Alan A McNab, Timothy Godfrey, et al.
Haematologica
|
September 6, 2015
Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma"
Simon J Harrison, Hang Quach, Andrew Spencer, et al.
Page
of 32
Search research articles
Search
Showing results (51-60 of 318) with videos related to
Sort By:
Page
of 32
The Australasian Journal of Dermatology
|
February 14, 2004
Treatment of primary cutaneous follicular centre lymphoma with rituximab: a report of two cases
Glen A Kennedy, Robert Blum, Christopher McCormack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Erdheim-Chester disease harboring the BRAF V600E mutation
Piers Blombery, Stephen Q Wong, Stephen Lade, et al.
Journal of the American Academy of Dermatology
|
November 14, 2006
Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases
Hope V Dinh, Christopher McCormack, Stephen Hall, et al.
European Journal of Haematology
|
July 5, 2007
Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison
H Miles Prince, Michael Adena, Dell Kingsford Smith, et al.
International Journal of Hematology
|
February 11, 2010
Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient
Alastair B Law, Gail Ryan, Stephen Lade, et al.
The Australasian Journal of Dermatology
|
November 21, 2024
Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib
Harmeet K Bhullar, Friyana Bhabha, Chris McCormack, et al.
Expert Review of Anticancer Therapy
|
March 28, 2008
Histone deacetylase inhibitors in lymphoma and solid malignancies
Walid Rasheed, Mark Bishton, Ricky W Johnstone, et al.
Leukemia & Lymphoma
|
February 7, 2009
Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma
Stefan Peinert, Sarah Kamel, John F Seymour, et al.
Ophthalmology
|
May 10, 2014
Adult orbital xanthogranuloma successfully treated with rituximab
Khami Satchi, Alan A McNab, Timothy Godfrey, et al.
Haematologica
|
September 6, 2015
Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma"
Simon J Harrison, Hang Quach, Andrew Spencer, et al.
Page
of 32